Interleukin-10 gene transfer to peritoneal mesothelial cells suppresses peritoneal dissemination of gastric cancer cells due to a persistently high concentration in the peritoneal cavity

被引:17
作者
Tanaka, F. [1 ]
Tominaga, K. [1 ]
Shiota, M. [2 ]
Ochi, M. [1 ]
Kuwamura, H. [1 ]
Tanigawa, T. [1 ]
Watanabe, T. [1 ]
Fujiwara, Y. [1 ]
Oshitani, N. [1 ]
Higuchi, K. [1 ]
Iwao, H. [2 ]
Arakawa, T. [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Grad Sch Med, Dept Pharmacol, Osaka 5458585, Japan
关键词
interleukin-10; peritoneal mesothelial cells; peritoneal dissemination; gastric cancer;
D O I
10.1038/sj.cgt.7701104
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Interleukin (IL)-10 has potent biological properties including an inhibitory action on the proliferation and metastasis of various cancer cells. However, it is difficult to maintain a high concentration of this cytokine as it has a short half life. In this study, we evaluated whether peritoneal mesothelial cells (PMCs) could be suitable for maintaining a high concentration of IL-10 using adenoviral gene transfer. We also evaluated the therapeutic effects of an intraperitoneal injection with adenoviral vector containing mouse IL-10 gene (Ad-mIL-10) using a mouse peritoneal dissemination model of MKN45 gastric cancer cells. We demonstrated that in vitro transfection efficiency of a recombinant adenovirus containing the bacterial beta-galactosidase gene (Ad-LacZ) was approximately 10-fold higher for primarily isolated PMCs than MKN45. The entire peritoneum was transfected until 3 weeks after an intraperitoneal Ad-LacZ injection. Ad-mIL-10 treatment increased intraperitoneal IL-10 levels until 3 weeks after treatment, and then significantly inhibited peritoneal cancer growth by inhibiting angiogenesis. This treatment also improved cachexia and prolonged mice survival. We thus concluded that IL-10 gene transfer in PMCs could be a new strategy for the prevention of peritoneal dissemination of gastric cancer due to the resulting persistently high IL-10 concentration in the peritoneal cavity.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 36 条
[11]  
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
[12]   Expression of mRNA for growth factors and extracellular matrix proteins after injury to cultured peritoneal cells: Does the healing process contribute to peritoneal ultrastructural alteration? [J].
Koki Fujikawa ;
Kimio Takai ;
Akinobu Suga ;
Katusuke Naito ;
Atushi Ohata ;
Shinya Nakasone ;
Takashi Horiuchi .
Journal of Artificial Organs, 2003, 6 (4) :253-259
[13]  
Fujiki F, 1997, CANCER RES, V57, P94
[14]  
GIOVARELLI M, 1995, J IMMUNOL, V155, P3112
[15]   DIFFUSIONAL TRANSPORT OF SOLUTES THROUGH MESENTERY AND PERITONEUM [J].
GOSSELIN, RE ;
BERNDT, WO .
JOURNAL OF THEORETICAL BIOLOGY, 1962, 3 (03) :487-&
[16]   Regulation of tumor growth and metastasis by interleukin-10: The melanoma experience [J].
Huang, SY ;
Ullrich, SE ;
Bar-Eli, M .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (07) :697-703
[17]  
Jayne DG, 2000, BRIT J CANCER, V82, P1233
[18]  
Kohno T, 2003, CANCER RES, V63, P5091
[19]   Interleukin-10 plasmid DNA inhibits subcutaneous tumor growth of Colon26 adenocarcinoma in mice [J].
Kokura, S ;
Yoshida, N ;
Ishikawa, T ;
Higashihara, H ;
Sakamoto, N ;
Takagi, T ;
Uchiyama, K ;
Naito, Y ;
Mazda, O ;
Okanoue, T ;
Yoshikawa, T .
CANCER LETTERS, 2005, 218 (02) :171-179
[20]  
Kundu N, 1998, INT J CANCER, V76, P713, DOI 10.1002/(SICI)1097-0215(19980529)76:5<713::AID-IJC17>3.0.CO